Faraguna, M.C.; Musto, F.; Crescitelli, V.; Iascone, M.; Spaccini, L.; Tonduti, D.; Fedeli, T.; Kullmann, G.; Canonico, F.; Cattoni, A.;
et al. Mucopolysaccharidosis-Plus Syndrome, a Rapidly Progressive Disease: Favorable Impact of a Very Prolonged Steroid Treatment on the Clinical Course in a Child. Genes 2022, 13, 442.
https://doi.org/10.3390/genes13030442
AMA Style
Faraguna MC, Musto F, Crescitelli V, Iascone M, Spaccini L, Tonduti D, Fedeli T, Kullmann G, Canonico F, Cattoni A,
et al. Mucopolysaccharidosis-Plus Syndrome, a Rapidly Progressive Disease: Favorable Impact of a Very Prolonged Steroid Treatment on the Clinical Course in a Child. Genes. 2022; 13(3):442.
https://doi.org/10.3390/genes13030442
Chicago/Turabian Style
Faraguna, Martha Caterina, Francesca Musto, Viola Crescitelli, Maria Iascone, Luigina Spaccini, Davide Tonduti, Tiziana Fedeli, Gaia Kullmann, Francesco Canonico, Alessandro Cattoni,
and et al. 2022. "Mucopolysaccharidosis-Plus Syndrome, a Rapidly Progressive Disease: Favorable Impact of a Very Prolonged Steroid Treatment on the Clinical Course in a Child" Genes 13, no. 3: 442.
https://doi.org/10.3390/genes13030442
APA Style
Faraguna, M. C., Musto, F., Crescitelli, V., Iascone, M., Spaccini, L., Tonduti, D., Fedeli, T., Kullmann, G., Canonico, F., Cattoni, A., Dell’Acqua, F., Rizzari, C., & Gasperini, S.
(2022). Mucopolysaccharidosis-Plus Syndrome, a Rapidly Progressive Disease: Favorable Impact of a Very Prolonged Steroid Treatment on the Clinical Course in a Child. Genes, 13(3), 442.
https://doi.org/10.3390/genes13030442
